Blogs | MedChemExpress

Pegdinetanib (BMS-844203) is a Selective VEGFR-2 Inhibitor

Pegdinetanib (BMS-844203) is a selective VEGFR-2 inhibitor with antitumor activity.
SZUH280 is a Potent And Selective PROTAC HDAC8 Degrader

SZUH280, a potent and selective PROTAC HDAC8 degrader, ,shows antitumor activity in an A549 nude mouse model.
Ganitumab (AMG 479) is an IGF1R mAb for Cancer Research

Ganitumab (AMG 479) is a recombinant human monoclonal antibody to the human IGF1R. Ganitumab can be used in research of cancer.
LY3177833 is an Orally Active CDC7 and pMCM2 Inhibitor

LY3177833 is an orally active CDC7 and pMCM2 inhibitor with IC50 values of 3.3 nM and 290 nM, respectively. LY3177833 is a senescence inducer
Parsatuzumab (RG 7414) is a Humanized mAb, Binding to EGFL7

Parsatuzumab (RG 7414) is a humanized monoclonal antibody, that acts as an immunomodulator, and binds to EGFL7.
AZ31 is a Highly Selective and Orally Active ATM Inhibitor

AZ31 is a potent, highly selective, and orally active ATM inhibitor, and is also a potent radiosensitizer in vitro.
BSP16 is an Orally Active Stimulator of Interferon Genes (STING)

BSP16 is a potent, orally active stimulator of interferon genes (STING) agonist. BSP16 has potent anti-cancer activity.
CQ211 is a Potent and Selective RIOK2 Inhibitor

CQ211 is a selective RIOK2 inhibitor (Kd=6.1 nM). CQ211 exhibits anti-proliferation inhibition activity against multiple cancer cell lines.
Tivantinib is a Selective c-Met Tyrosine Kinase Inhibitor

Tivantinib is a selective and orally active inhibitor of c-MET. Tivantinib can be used for the research of cancer.
CBL0137 is an Histone Chaperone FACT Inhibitor

CBL0137 is an inhibitor of the histone chaperone, FACT. CBL0137 activates p53 and inhibits NF-κB with EC50s of 0.37 and 0.47 µM, respectively.

Name
Email *

	Sorry, but the email address you supplied was invalid.

Blogs (39)